'Fast but not so furious': A condensed step‐up dosing schedule of teclistamab for relapsed/refractory multiple myeloma

Autor: Kevin C. Graf, James A Davis, Alyssa Cendagorta, Katelynn Granger, Kelly J. Gaffney, Kimberly Green, Brian T Hess, Hamza Hashmi

Publikováno v: eJHaem, Vol 5, Iss 4, Pp 793-797 (2024)

Abstract Teclistamab is a B‐cell maturation antigen (BCMA)‐directed bispecific T‐cell engager approved for relapsed‐refractory multiple myeloma (RRMM). Cytokine release syndrome (CRS) and Immune effector cell‐associated neurotoxicity syndro

Externí odkaz: https://doaj.org/article/52d53d0c9d374fbfa2c3a623e2dafa7c

Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study

Autor: Juan P. Alderuccio, Weiyun Z. Ai, John Radford, Melhem Solh, Kirit M. Ardeshna, Matthew A. Lunning, Brian T. Hess, Pier L. Zinzani, Anastasios Stathis, Carmelo Carlo-Stella, Mehdi Hamadani, Brad S. Kahl, David Ungar, Turk Kilavuz, Eric Yu, Yajuan Qin, Paolo F. Caimi

Publikováno v: Alderuccio, J P, Ai, W Z, Radford, J, Solh, M M, Ardeshna, K M, Lunning, M, Hess, B, Luigi Zinzani, P, Stathis, A, Carlo Stella, C, Hamadani, M, Kahl, B S, Ungar, D, Kilavuz, T, Yu, E, Qin, Y G & Caimi, P F 2022, ' Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma : a subgroup analysis from the LOTIS-2 study ', Blood Advances, vol. 6, no. 16, pp. 4736-4739 . https://doi.org/10.1182/bloodadvances.2022007782

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08bd9d4d9eea52ddc1ec3d548dcc2c67
https://doi.org/10.1182/bloodadvances.2022007782

Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-Cell Lymphomas Treated with Chimeric Antigen Receptor T-Cell (CART) Therapy

Autor: Reem Karmali, Narendranath Epperla, Geoffrey Shouse, Jason T. Romancik, Tamara K. Moyo, Vaishalee P. Kenkre, Thomas A. Ollila, Lindsey A. Fitzgerald, Brian T. Hess, Andrew M. Evens, Ishan Roy, Joanna Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul Bhansali, Elyse I. Harris, McKenzie Sorrell, Jieqi Liu, Imran A. Nizamuddin, Shuo Ma, Jonathan Moreira, Jane N. Winter, Barbara Pro, Deborah M. Stephens, Alexey V Danilov, Nirav N. Shah, Jonathon B. Cohen, Stefan K. Barta, Pallawi Torka, Leo I. Gordon

Publikováno v: Blood. 140:10955-10957

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::184047777d28c81fce1a16d1038919eb
https://doi.org/10.1182/blood-2022-160431

Double Hit/Double Expressor Lymphomas: A Multicenter Analysis of Survival Outcomes with CD19-Directed CAR T-Cell Therapy

Autor: Joanna Zurko, Geoffrey Shouse, Pallawi Torka, Tamara K. Moyo, Jason T. Romancik, Imran A. Nizamuddin, Kaitlin Annunzio, Jieqi Liu, Stefan K. Barta, Robert Ferdman, Rahul Bhansali, Jonathon B. Cohen, Sayan Mullick Chowdhury, Nirav N. Shah, Elyse I. Harris, Vaishalee P. Kenkre, McKenzie Sorrell, Brian T. Hess, Deborah M. Stephens, Lindsey A. Fitzgerald, Thomas A. Ollila, Ishan Roy, Shuo Ma, Jane N. Winter, Barbara Pro, Jonathan Moreira, Leo I. Gordon, Alexey V Danilov, Andrew M. Evens, Narendranath Epperla, Reem Karmali

Publikováno v: Blood. 140:375-377

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::523e439735c6874326c62cac63567a1d
https://doi.org/10.1182/blood-2022-163438

Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation

Autor: Lindsey Hendrickson, Iya Znoyko, James Kalmuk, Daynna J. Wolff, Irl Brian Greenwell, Zane Chiad, Cynthia A. Schandl, Sandra Mazzoni, Nina D. Wagner-Johnston, Brian T. Hess

Publikováno v: Cancer Genetics. :18-22

Richter transformation (RT) refers to the development of an aggressive lymphoma in patients with pre-existing chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). It carries a poor prognosis secondary to poor response to therapy or rapi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a170bec3590538e5ba0754e467c66eaf
https://doi.org/10.1016/j.cancergen.2021.10.003